Literature DB >> 19184543

Expression, purification, and characterization of hepatitis B virus surface antigens (HBsAg) in yeast Pichia Pastoris.

Rushi Liu1, Qinlu Lin, Yi Sun, Xiangyang Lu, Yilan Qiu, Ye Li, Xiangrong Guo.   

Abstract

Prevention of the prevalence of HB depends upon the development of efficient diagnostic reagent and preventive vaccine. Pichia pastoris offers many advantages over the other expression systems in the production of recombinant HBsAg. In this study, we reported that the recombinant P. pastoris strains were cultured in shake flasks and then scaled up in a 5.0-l bioreactor: approximately 27 mg/l of the protein and the maximal cell OD at 600 nm of 310 were achieved in the bioreactor. The recombinant HBsAg was purified by three steps of purification procedures. SDS-PAGE showed that the purified recombinant HBsAg constituted only one homogeneous band of approximately 24 kDa. CsCl density gradient ultracentrifugation assay indicated that the density of the HBsAg was 1.2 mg/ml, which was in agreement with the natural HBsAg, the HBsAg expressed in Saccharomyces cerevisiae and in mammalian cells. Electron microscope observation revealed that the purified recombinant HBsAg was homogeneous 22-nm particles, suggesting the HBsAg expressed in P. pastoris was self-assembled to virus-like structures. Competitive ELISA indicated that P. pastoris-derived HBsAg possessed the excellent immunoreaction with anti-HBsAg. Animal immunization showed that the immunogenicity of P. pastoris-derived HBsAg was superior to that of S. cerevisiae-derived HBsAg. Together, our results demonstrated that the recombinant HBsAg expressed in P. pastoris could provide promising, inexpensive, and large-scale materials for the diagnostic reagent and vaccine to prevent HBV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184543     DOI: 10.1007/s12010-009-8527-x

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  9 in total

1.  Multispot, label-free biodetection at a phantom plastic-water interface.

Authors:  Fabio Giavazzi; Matteo Salina; Roberto Cerbino; Mattia Bassi; Davide Prosperi; Erica Ceccarello; Francesco Damin; Laura Sola; Marco Rusnati; Marcella Chiari; Bice Chini; Tommaso Bellini; Marco Buscaglia
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-21       Impact factor: 11.205

2.  Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.

Authors:  Peter Pushko; Lindsey M Pujanauski; Xiangjie Sun; Melissa Pearce; Rachmat Hidajat; Thomas Kort; Louis M Schwartzman; Irina Tretyakova; Liu Chunqing; Jeffery K Taubenberger; Terrence M Tumpey
Journal:  Vaccine       Date:  2015-07-21       Impact factor: 3.641

3.  Effect of revaccination using different schemes among adults with low or undetectable anti-HBs titers after hepatitis B virus vaccination.

Authors:  Chao-Shuang Lin; Shi-Bin Xie; Jing Liu; Zhi-Xin Zhao; Yu-Tian Chong; Zhi-Liang Gao
Journal:  Clin Vaccine Immunol       Date:  2010-08-18

4.  High level production of stable human serum albumin in Pichia pastoris and characterization of the recombinant product.

Authors:  Nitu Maity; Avijeet S Jaswal; Ashwani Gautam; Vikram Sahai; Saroj Mishra
Journal:  Bioprocess Biosyst Eng       Date:  2022-01-09       Impact factor: 3.210

5.  Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus.

Authors:  Xiaohui Li; Peter Pushko; Irina Tretyakova
Journal:  J Vaccines Vaccin       Date:  2015-06-30

6.  Exposition of hepatitis B surface antigen (HBsAg) on the surface of HEK293T cell and evaluation of its expression.

Authors:  Mina Mirian; Razieh Taghizadeh; Hossein Khanahmad; Mansour Salehi; Ali Jahanian-Najafabadi; Hojjat Sadeghi-Aliabadi; Shirin Kouhpayeh
Journal:  Res Pharm Sci       Date:  2016-10

7.  Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.

Authors:  Edith Reuschel; Wolfgang Jilg; Birgit Seelbach-Goebel; Ludwig Deml
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

8.  Whole Pichia pastoris yeast expressing measles virus nucleoprotein as a production and delivery system to multimerize Plasmodium antigens.

Authors:  Daria Jacob; Claude Ruffie; Myriam Dubois; Chantal Combredet; Rogerio Amino; Pauline Formaglio; Olivier Gorgette; Gérard Pehau-Arnaudet; Charline Guery; Odile Puijalon; Jean-Christophe Barale; Robert Ménard; Frédéric Tangy; Monica Sala
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

9.  Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.

Authors:  Anna Czarnota; Jolanta Tyborowska; Grażyna Peszyńska-Sularz; Beata Gromadzka; Krystyna Bieńkowska-Szewczyk; Katarzyna Grzyb
Journal:  Microb Cell Fact       Date:  2016-04-13       Impact factor: 5.328

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.